Singapore markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,035.70 +957.98 (+1.43%) CMC Crypto 200
1,374.09 +43.48 (+3.27%)
West Pharmaceutical Services, Inc. (WST)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 20.66B |
| Enterprise value | 20.52B |
| Trailing P/E | 40.51 |
| Forward P/E | 38.02 |
| PEG ratio (5-yr expected) | 5.14 |
| Price/sales (ttm) | 7.38 |
| Price/book (mrq) | 8.02 |
| Enterprise value/revenue | 7.13 |
| Enterprise value/EBITDA | 26.84 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -22.63% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 415.73 |
| 52-week low 3 | 265.00 |
| 50-day moving average 3 | 325.81 |
| 200-day moving average 3 | 354.58 |
Share statistics
| Avg vol (3-month) 3 | 625.29k |
| Avg vol (10-day) 3 | 952.34k |
| Shares outstanding 5 | 72.54M |
| Implied shares outstanding 6 | 72.84M |
| Float 8 | 72.05M |
| % held by insiders 1 | 0.57% |
| % held by institutions 1 | 95.86% |
| Shares short (15 Jul 2024) 4 | 1.24M |
| Short ratio (15 Jul 2024) 4 | 2.1 |
| Short % of float (15 Jul 2024) 4 | 2.23% |
| Short % of shares outstanding (15 Jul 2024) 4 | 1.70% |
| Shares short (prior month 14 Jun 2024) 4 | 1.22M |
Dividends & splits
| Forward annual dividend rate 4 | 0.8 |
| Forward annual dividend yield 4 | 0.28% |
| Trailing annual dividend rate 3 | 0.77 |
| Trailing annual dividend yield 3 | 0.28% |
| 5-year average dividend yield 4 | 0.25 |
| Payout ratio 4 | 11.24% |
| Dividend date 3 | 07 Aug 2024 |
| Ex-dividend date 4 | 31 Jul 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 27 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 30 Jun 2024 |
Profitability
| Profit margin | 18.25% |
| Operating margin (ttm) | 17.98% |
Management effectiveness
| Return on assets (ttm) | 10.85% |
| Return on equity (ttm) | 19.72% |
Income statement
| Revenue (ttm) | 2.88B |
| Revenue per share (ttm) | 39.01 |
| Quarterly revenue growth (yoy) | -6.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 767.8M |
| Net income avi to common (ttm) | 524.9M |
| Diluted EPS (ttm) | 7.03 |
| Quarterly earnings growth (yoy) | -28.20% |
Balance sheet
| Total cash (mrq) | 446.2M |
| Total cash per share (mrq) | 6.15 |
| Total debt (mrq) | 310.7M |
| Total debt/equity (mrq) | 12.06% |
| Current ratio (mrq) | 2.34 |
| Book value per share (mrq) | 35.49 |
Cash flow statement
| Operating cash flow (ttm) | 752.4M |
| Levered free cash flow (ttm) | 186.56M |
© 2024 Yahoo. All rights reserved.